Related Experiment Video

Updated: Jun 4, 2026

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

Drug discovery: A question of library design

Philip J Hajduk, Warren R J D Galloway, David R Spring

    Nature
    |February 5, 2011
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode
    09:19

    NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode

    Published on: June 4, 2021

    Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow
    08:58

    Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow

    Published on: October 17, 2025

    Related Experiment Videos

    Last Updated: Jun 4, 2026

    Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
    06:26

    Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

    Published on: May 16, 2021

    NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode
    09:19

    NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode

    Published on: June 4, 2021

    Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow
    08:58

    Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow

    Published on: October 17, 2025

    Related Concept Videos

    Drug Discovery: Overview01:26

    Drug Discovery: Overview

    Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
    Structure-Activity Relationships and Drug Design01:28

    Structure-Activity Relationships and Drug Design

    Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
    SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...

    Articles linked to this work by shared authors, journal, and citation graph.

    Selective Inhibition of CK2: Emerging Strategies and Future Directions.

    Journal of medicinal chemistry·2026

    Cysteine Re-bridging Using Divinyl Pyrimidine Reagents for the Generation of Antibody-Drug Conjugates.

    Methods in molecular biology (Clifton, N.J.)·2026

    Recent advances in antibody-drug conjugates.

    Current opinion in chemical biology·2026

    Peptide Marriages: Modular Assembly of Multi-Agonist Therapeutics.

    Chemistry (Weinheim an der Bergstrasse, Germany)·2026

    Multicomponent Stapling of Glucagon-Like Peptide-1 Enables Receptor-Guided PROTAC Delivery.

    Angewandte Chemie (International ed. in English)·2026

    Boosting peptide half-life: enabling efficient generation of Fc-peptide conjugates.

    Chemical science·2026

    Aptamer-based nanoparticle drug delivery system designed for targeting GPC3-positive liver cancer.

    Journal of pharmaceutical analysis·2026

    Design and optimization of nafimidone-inspired hybrid scaffolds targeting NaV1.2 for antiepileptic therapy with reduced cardiac liability.

    Bioorganic chemistry·2026

    Structure-informed characterization of a TLR2-binding scFv reveals a CDR-centered recognition model.

    Biochemical and biophysical research communications·2026

    Safety assessment of the substance 1,3-benzenedicarboxamide, 5-[[[cis-4-(1,1-dimethylethyl)cyclohexyl]carbonyl]amino]-N1,N3-bis[cis-4-(1-methylethyl)cyclohexyl]- for use in food contact materials.

    EFSA journal. European Food Safety Authority·2026

    Systems pharmacology, structural modeling, and experimental validation reveal retinoic acid as a modulator of immune-fibrotic networks in chronic kidney disease.

    Naunyn-Schmiedeberg's archives of pharmacology·2026

    New paradigm of q-CAR drug development targeting disease-specific protein conformations.

    npj drug discovery·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us